Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells-Reference-Cited by-同舟云学术

Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells

Published:2023-09 Issue: Volume:334 Page:199173
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Golden Joseph W.^ORCID,Fitzpatrick Collin J.,Suschak John J.,Clements Tamara L.,Ricks Keersten M.^ORCID,Sanchez-Lockhart Mariano,Garrison Aura R.^ORCID

Funder

US Army Medical Research Institute of Infectious Diseases

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference46 articles.

1. World Health Organization, 2015. Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. December 8-9.

2. World Health Organization, 2018. 2018 Annual review of diseases prioritized under the Research and Development Blueprint.

3. Immunological analysis of a CCHFV mRNA vaccine candidate in mouse models;Aligholipour Farzani;Vaccines,2019

4. Bovine herpesvirus type 4 (BoHV-4) vector delivering nucleocapsid protein of crimean-congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in IFNalpha/beta/gammaR-/- Mice Models;Aligholipour Farzani;Viruses,2019

5. Nucleoside-modified mRNA vaccines protect IFNAR(-/-) mice against crimean-congo hemorrhagic fever virus infection;Appelberg;J. Virol.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purification and Characterization of Soluble Recombinant Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Gc expressed in mammalian 293F Cells;2024-01-23